More Globe Newswire

View Older Stories View Newer Stories

Dec 7, 2025 07:54AM Manufacturing Expert James Gizzi of Rochester Discusses How to Choose a CNC Machine Shop in HelloNation
Dec 7, 2025 07:50AM Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relaps
Dec 7, 2025 07:49AM How Roofing Expert Tom Meadows of Ann Arbor Explains Roof Repair vs. Roof Replacement for HelloNation
Dec 7, 2025 07:00AM Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
Dec 7, 2025 06:00AM New Crypto Mutuum Finance Completes Phase 1 Roadmap Milestones, Builds Momentum Into Phase 2
Dec 7, 2025 04:09AM 2025 "Silk Road for All Children" International Children's Literature Week The 10th Fairy Tales Conference Held in Wuyi, China
Dec 7, 2025 04:00AM Funding Reaches $19.2M as Mutuum Finance (MUTM) Presale Moves Toward Full Allocation
Dec 6, 2025 08:14PM SALI Showcases Global Ambition with Times Square Billboard Campaign, Marking a New Milestone in Its Journey Toward a Global Power Tool Accessories Empire
Dec 6, 2025 05:30PM TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
Dec 6, 2025 05:30PM Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual M
Dec 6, 2025 03:30PM BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Dec 6, 2025 02:01PM Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
Dec 6, 2025 02:01PM Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
Dec 6, 2025 02:00PM Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Dec 6, 2025 02:00PM Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
Dec 6, 2025 01:51PM THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
Dec 6, 2025 12:39PM BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program
Dec 6, 2025 12:37PM Roofing Expert Keith Miller Clarifies Why Flashing Is the Source of Many Roof Leaks in HelloNation
Dec 6, 2025 12:00PM RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherby’s Transparency Initiative
Dec 6, 2025 11:27AM Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review
Dec 6, 2025 11:24AM Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days
Dec 6, 2025 11:00AM Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
Dec 6, 2025 10:15AM Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
Dec 6, 2025 10:00AM JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
Dec 6, 2025 10:00AM JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
Dec 6, 2025 09:30AM Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at
Dec 6, 2025 09:30AM Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematolog
Dec 6, 2025 09:30AM Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Dec 6, 2025 08:30AM Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
Dec 6, 2025 08:05AM Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist
Dec 6, 2025 08:05AM Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meet
Dec 6, 2025 08:05AM Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compo
Dec 6, 2025 08:00AM Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
Dec 6, 2025 08:00AM Canada’s Tenth Costco Business Centre is now open in East Gwillimbury
Dec 6, 2025 08:00AM Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
Dec 6, 2025 08:00AM Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
Dec 6, 2025 08:00AM Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Societ
Dec 6, 2025 07:15AM BI DeFi Launches New Daily Yield Plan as Demand for Accessible Crypto Income Solutions Grows
Dec 6, 2025 07:00AM DeFi Crypto Mutuum Finance Prepares for 20% Price Increase as Phase 6 Nears Completion
Dec 6, 2025 06:57AM New Crypto Coin Mutuum Finance Nears 100% of Phase 6 Allocation as Price Shift Approaches
Dec 6, 2025 02:00AM Scatec starts commercial operation at Grootfontein solar power plant in South Africa
Dec 6, 2025 12:55AM Cardinal Point Wealth Management Releases New 2025 Cross-Border Retirement Guide for High-Net-Worth Families
Dec 5, 2025 10:11PM Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
Dec 5, 2025 09:00PM Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease
Dec 5, 2025 08:00PM ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress
Dec 5, 2025 07:13PM Copper Quest Closes $1,927,000 Private Placement
Dec 5, 2025 06:30PM AB Value Partners, L.P. Announces Proposed Settlement of Stockholder Class Action on Behalf of Former Holders of Orbit/FR, Inc. Common Stock - ORFR
Dec 5, 2025 06:25PM HNI Corporation Announces Expiration and Final Results of Exchange Offer
Dec 5, 2025 06:00PM Guardian Capital Announces Estimated 2025 Annual Non-Cash Distributions for Guardian Capital ETFs
Dec 5, 2025 06:00PM Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
View Newer Stories View Older Stories